Briol, Tertulo M.
HRN: 22-75-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2023
CIPROFLOXACIN 500MG (TAB)
03/16/2023
03/22/2023
PO
500 Mg
BID
Malignant Otitis Media
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes